SynthesisInternational journal of colorectal disease2023

Comparative efficacy and safety of combination therapy with infliximab for Crohn's disease: a systematic review and network meta-analysis.

Bing Han et al.PubMed ↗Publisher ↗

No numbers read from the abstract.